Supplementary Material for: Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome

  • L. A. Jonker (Creator)
  • C.A. Lebbink (Creator)
  • M. C. J. Jongmans (Contributor)
  • R. A. J. Nievelstein (Contributor)
  • J.H.M. Merks (Princess Máxima Center for Pediatric Oncology) (Contributor)
  • Els Nieveen van Dijkum (Contributor)
  • T. P. Links (Creator)
  • N. Hoogerbrugge (Creator)
  • Adrianus van Trotsenburg (Contributor)
  • Santen H.M. Van Santen (Princess Máxima Center for Pediatric Oncology, Utrecht University) (Contributor)

Dataset

Description

Background: PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in the PTEN gene. Children with a germline PTEN mutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guideline...
Date made available2020
PublisherKarger Publishers

Access Dataset

Cite this